Literature DB >> 23643422

Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285.

Maria G Stathopoulou1, Pedro Monteiro, Payman Shahabi, Eva Peñas-Lledó, Said El Shamieh, Luís Silva Santos, Nathalie Thilly, Gerard Siest, Adrián Llerena, Sophie Visvikis-Siest.   

Abstract

Entities:  

Keywords:  Blood pressure; CYP2C19 polymorphism; Calcium-channel blockers; Clopidogrel; Synergy

Mesh：

Substances：

Year:  2013        PMID： 23643422     DOI： 10.1016/j.ijcard.2013.04.097

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

Review 1.  Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.

Authors:  I Fricke-Galindo; C Céspedes-Garro; F Rodrigues-Soares; M E G Naranjo; Á Delgado; F de Andrés; M López-López; E Peñas-Lledó; A LLerena
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

2.  Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution.

Authors:  Ramatoulie E Janha; Archibald Worwui; Kenneth J Linton; Seif O Shaheen; Fatoumatta Sisay-Joof; Robert T Walton
Journal:  BMC Evol Biol       Date:  2014-04-01       Impact factor: 3.260
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.